Literature DB >> 25217790

'Don't delay, start today': delaying levodopa does not delay motor complications.

Susan H Fox1, Anthony E Lang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25217790     DOI： 10.1093/brain/awu212

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  9 in total

Review 1.  Dyskinesias and levodopa therapy: why wait?

Authors:  Michele Matarazzo; Alexandra Perez-Soriano; A Jon Stoessl
Journal:  J Neural Transm (Vienna)       Date:  2018-02-10       Impact factor: 3.575

Review 2.  Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.

Authors:  Peter Jenner
Journal:  Transl Neurodegener       Date:  2015-02-12       Impact factor: 8.014

3.  Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Authors:  Emanuele Cereda; Roberto Cilia; Margherita Canesi; Silvana Tesei; Claudio Bruno Mariani; Anna Lena Zecchinelli; Gianni Pezzoli
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

4.  Screening of Parkinsonian subtle fine-motor impairment from touchscreen typing via deep learning.

Authors:  Dimitrios Iakovakis; K Ray Chaudhuri; Lisa Klingelhoefer; Sevasti Bostantjopoulou; Zoe Katsarou; Dhaval Trivedi; Heinz Reichmann; Stelios Hadjidimitriou; Vasileios Charisis; Leontios J Hadjileontiadis
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

5.  Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Fábio G Teixeira; Helena Vilaça-Faria; Ana V Domingues; Jonas Campos; António J Salgado
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

6.  Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study.

Authors:  Gloria Martí-Andrés; Rayco Jiménez-Bolaños; José Matias Arbelo-González; Javier Pagonabarraga; Carmen Duran-Herrera; Rafael Valenti-Azcarate; Mª Rosario Luquin
Journal:  Brain Sci       Date:  2019-10-11

7.  Effects of daily L-dopa administration on learning and brain structure in older adults undergoing cognitive training: a randomised clinical trial.

Authors:  Alexander V Lebedev; Jonna Nilsson; Joanna Lindström; William Fredborg; Ulrika Akenine; Carolina Hillilä; Pia Andersen; Gabriela Spulber; Elizabeth C M de Lange; Dirk-Jan van den Berg; Miia Kivipelto; Martin Lövdén
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379

8.  Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort.

Authors:  Han-Joon Kim; Sarah Mason; Thomas Foltynie; Sophie Winder-Rhodes; Roger A Barker; Caroline H Williams-Gray
Journal:  Mov Disord       Date:  2019-11-11       Impact factor: 10.338

9.  Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.

Authors:  Roberto Cilia; Emanuele Cereda; Albert Akpalu; Fred Stephen Sarfo; Momodou Cham; Ruth Laryea; Vida Obese; Kenneth Oppon; Francesca Del Sorbo; Salvatore Bonvegna; Anna Lena Zecchinelli; Gianni Pezzoli
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.